OTC Watch

All stocks / GTHP

GUIDED THERAPEUTICS INC GTHP

Guided Therapeutics (GTHP): no warning signs from our rules in the last 12 months and the latest annual figures in plain language. Each fact links to its SEC filing.

Estimated float OTCQBGeorgia, USA
Live quote on OTC Markets

Market listing

Full name
GUIDED THERAPEUTICS INC
Market tier
OTCQB
Trading status
Active
Last trade
Nov 16
Website
www.guidedinc.com
Source: Stockwatch, 2026-11-17

News headlines

Guided Therapeutics Provides Update on its Cervical Cancer Screening Study with Turkiye's Ministry of Health
2026-11-04 09:00 · News Release
Guided Therapeutics Reaches Collaborative Agreement with Turkiye's Ministry of Health to Become Primary Screening Test for Cervical Cancer
2026-09-09 09:00 · News Release
Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor
2026-07-22 09:00 · News Release
Guided Therapeutics Announces New Agreement with Distribution Partner Yuanshuo Medical Instruments Corporation
2026-07-14 09:00 · News Release
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA
2026-06-16 09:00 · News Release
Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
2026-03-31 09:00 · News Release
SEDAR Preliminary Long Form Prospectus
2025-12-19 11:52 · SEDAR Preliminary Long Form Prospectus
Analysis of Guided Therapeutics' FDA Study Data Reveals Compelling Clinical Need for LuViva
2025-12-17 09:00 · News Release
Guided Therapeutics Receives $88,000 Payment as Third Installment of $700,000 Purchase Order with Chinese Distributor
2025-12-11 09:00 · News Release
Guided Therapeutics Inks Initial $200,000 Deal with New Distribution Partner Yuanshuo Medical Instruments Corporation
2025-11-19 09:00 · News Release
Headlines only, with links to the full item. Company press releases are written by the company.

The financial report, and what it means

Annual figures to 2025-12-31
The report says
Revenue
$767,000
Net loss
($3,196,000)
What it means

It spends more than it earns

Under strain

Customers paid it $767,000 in the year. It lost $3.2 million. For every $1 that came in, about $5.17 went out.

The report says
Cash and cash equivalents
$63,000
Net cash used in operating activities
($1,068,000)
What it means

The cash could run out soon

Under strain

It had $63,000 in the bank and used about $89,000 a month. At that pace the money lasts less than a month unless it borrows or sells more shares.

The report says
Total assets
$1,324,000
Total liabilities
$7,330,000
What it means

It owes more than it owns

Under strain

Everything the company owns adds up to $1.3 million. Its debts and unpaid bills add up to $7.3 million. That is about $5.54 owed for every $1 owned.

What this adds up to

3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.

Signals

Estimated float2026-11-11

Estimated float about 64,239,870 shares as of 2026-11-11: 98,187,564 outstanding minus 33,947,694 held by 3 reporting insider(s).

Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record

Shares outstanding

Source: SEC filings
2025-12-31
86,154
2026-03-27
96.4M
2026-03-31
96.5M
2026-05-12
96.5M
2026-06-30
96.5M
2026-08-07
96.5M
2026-09-30
98,188
2026-11-11
98.2M

Price chart

Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets

Recent filings

2026-11-16 10-QFORM 10-Q
2026-10-27 4FORM 4
2026-08-13 10-QFORM 10-Q
2026-05-15 10-QFORM 10-Q
2026-05-05 4FORM 4
2026-04-07 4FORM 4
2026-04-07 4FORM 4
2026-04-07 4FORM 4
2026-03-31 10-KFORM 10-K
2026-03-12 4FORM 4
2026-03-10 8-KFORM 8-K
2026-03-04 4FORM 4

Common questions about GTHP

Does GTHP file reports with the SEC?

Yes. Guided Therapeutics files with the SEC under company number 0000924515. The most recent filing we hold is a 10-Q dated 2026-11-16.

Source record

How many GTHP shares are outstanding?

98,187,564 shares as of 2026-11-11, as reported to the SEC.

Source record

Has GTHP filed reports late?

We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.

Is Guided Therapeutics making money?

Customers paid it $767,000 in the year. It lost $3.2 million. For every $1 that came in, about $5.17 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)

Source record